Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05IPO
|
||||
Former ID |
DCL000732
|
||||
Drug Name |
BTS-79018
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Terminated | [536463] | ||
Company |
Abbott
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H27ClN2O3
|
||||
Canonical SMILES |
COC1=CC=CC=C1N2CCC(CC2)CNCC3COC4=C(O3)C=C(C=C4)Cl
|
||||
InChI |
1S/C22H27ClN2O3/c1-26-20-5-3-2-4-19(20)25-10-8-16(9-11-25)13-24-14-18-15-27-21-7-6-17(23)12-22(21)28-18/h2-7,12,16,18,24H,8-11,13-15H2,1H3
|
||||
InChIKey |
QHLRKDSRGUZHSH-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 170353-17-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | D(3) dopamine receptor | Target Info | Binder | [536463] | |
5-hydroxytryptamine 1A receptor | Target Info | Binder | [536463] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.